| J2777 | Injection, faricimab‑svoa, 0.1 mg | 27,060 | $30 | $784.7K |
| J0178 | Injection, aflibercept, 1 mg | 490 | $690 | $334.4K |
| J2778 | Injection, ranibizumab, 0.1 mg | 850 | $180 | $153.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,220 | $90 | $108.2K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 830 | $90 | $76.7K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 1,320 | $30 | $36.9K |
| J7999 | Compounded drug, not otherwise classified | 50 | $70 | $2.9K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 20 | $120 | $2.3K |
| 76512 | The provider uses B–scan ultrasound imaging, with or without a non–qualitative A–scan superimposed, to examine the intraocular and orbital structures. | 60 | $30 | $1.9K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 20 | $120 | $1.9K |